SEC Tracker
Get the app
LIFD · XBRL financial data

LFTD Partners financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (LIFD's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue5,34431,65757,41751,61137,32536,921
Cost of revenue3,40715,71636,42331,90624,57024,300
Cost of goods and services sold14733936,42331,90624,57024,300
Gross profit1,93715,94120,99319,70412,75512,621
Research and development——2020——
Selling, general and administrative134—————
Total operating expenses3,4558,16011,18117,29413,52811,707
Operating income (loss)(1,518)7,7819,8132,410(773)913
Interest income8111———
Interest expense65142120111——
Other income (expense)(16)629181347(1,608)(25,339)
Income tax expense (benefit)07,1672,798598524433
Net income (loss)(1,535)5,8007,1962,159(1,857)(24,859)
Earnings per share, basic USD per share(0.29)0.500.510.15(0.13)(1.68)
Earnings per share, diluted USD per share(0.29)0.430.450.13(0.13)(1.68)
Weighted average shares, basic thousands of shares5,92711,40314,08114,55514,80314,823
Weighted average shares, diluted thousands of shares5,92713,36015,86316,43914,80314,823

Balance sheet

CSV

Fiscal years (LIFD's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Cash and cash equivalents4391,6033,5314,3582,1471,767
Accounts receivable1,4133,4612,4103,5862,3592,532
Inventory6413,8106,02410,1759,31610,958
Total current assets3,26513,15313,85421,66916,92815,691
Property and equipment, net1354331,0202,9962,7052,273
Right-of-use asset8764976271,119888
Goodwill22,29322,29322,29323,09323,0930
Total assets27,82739,41941,13251,34747,31619,273
Accrued liabilities1—————
Total current liabilities2,30911,9066,2108,6876,0845,162
Total deposits————1,0001,000
Lease liability, non-current—51384464938680
Total liabilities6,20811,9576,59512,5299,8116,640
Accumulated deficit(17,141)(11,415)(4,239)(2,097)(3,968)(28,840)
Total stockholders' equity21,61927,46234,53838,81837,50412,632
Total liabilities and equity27,82739,41941,13251,34747,31619,273
Common shares outstanding (cover page) thousands of shares9,76313,97814,51314,80614,82314,823

Cash flows

CSV

Fiscal years (LIFD's year ends in late December)

In thousands of dollarsDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Net income (loss)(1,535)5,8007,1962,159(1,857)(24,859)
Stock-based compensation1,39400———
Depreciation and amortization1690192426521553
Net cash from operating activities(338)5,6233,037639(960)1,322
Purchases of property and equipment70368916790314122
Net cash from investing activities(3,510)(447)(916)(2,517)(480)(122)
Proceeds from issuing common stock005000—
Share repurchases343415002400
Dividends paid19812————
Net cash from financing activities(98)(4,012)(193)3,705(771)(2,580)
Net change in cash(3,946)1,164————

Compare with peers

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
LFTD Partners1,5048,705(555)*14.8M2.7 quarters 10-QJun 30, 2026
Natural Alternatives International7,388not reported(1,066)*22.1M6.9 quarters 10-KJun 30, 2026
PharmaCyte Biotech17,7390(781)10.7M22.8 quarters 10-QJul 31, 2026
Vyome Holdings7,88827(904)*7.0M8.7 quarters 10-QJun 30, 2026
AIM ImmunoTech9,90026(4,590)*30.4M2.2 quarters 10-QJun 30, 2026
Adial Pharmaceuticals28,712not reported(6,363)*2.6M4.5 quarters 10-Q/AJun 30, 2026
Biomerica2,7331,265(802)4.6M3.4 quarters 10-QAug 31, 2026
Protagenic Therapeutics, Inc.\new566not reported(944)1.8M0.6 quarters 10-QJun 30, 2026
Adia Nutrition128485(109)*94.4M1.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.